期刊
BRITISH JOURNAL OF CANCER
卷 96, 期 12, 页码 1849-1854出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.bjc.6603824
关键词
immune surveillance; regulatory T cells; methylcholanthrene
类别
资金
- Medical Research Council [G117/488, G0500617] Funding Source: researchfish
- Medical Research Council [G117/488, G0500617] Funding Source: Medline
- Worldwide Cancer Research [05-0028] Funding Source: Medline
- MRC [G117/488, G0500617] Funding Source: UKRI
Burnet proposed in the 1950's that the immune system is engaged in identifying and destroying abnormal cancerous cells. This process, termed immune surveillance, has been at the centre of intense debate for decades. Results using immunodeficient mice lend support to the immune surveillance hypothesis. We surmised that immune surveillance would be hampered by the inhibitory effect of naturally occurring FoxP3(+) regulatory T cells, a population of T cells shown to be present at an increased frequency in a variety of human tumours. The carcinogen, methylcholanthrene was injected subcutaneously into mice and the steady development of fibrosarcomas was observed over approximately 200 days. These fibrosarcomas were strikingly infiltrated with FoxP3(+) regulatory T cells implying that these cells impinge upon immune-mediated rejection of the tumour. This was confirmed by partial ablation of FoxP3(+) regulatory T-cell activity, which resulted in a marked reduction in tumour incidence. The reduction of tumour incidence was ablated in mice that lacked interferon gamma. These data offer strong support for the concept of immune surveillance and indicate that this process is limited by the inhibitory effect of FoxP3(+) regulatory T cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据